Picture of BSF Enterprise logo

BSFA BSF Enterprise Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-1.25%
3m-12.61%
6m-29.61%
1yr-56.29%
Volume Change (%)
10d/3m-84.08%
Price vs... (%)
52w High-59.5%
50d MA-2.69%
200d MA-14.51%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-59.3%
Return on Equity-46.41%
Operating Margin-7150.56%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202530th Sep 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of BSF Enterprise EPS forecast chart

Profile Summary

BSF Enterprise PLC is a United Kingdom-based biotech company. The Company develops and commercializes cell-based tissue engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. The principal activity of the Company is to undertake the acquisition of businesses in the biotechnology, marketing and e-commerce sectors. The Company operates through its wholly owned subsidiaries, 3D Bio-Tissues Limited (3DBT), Lab Grown Leather Limited (LGL), Kerato Limited (Kerato), and BSF Enterprise (Hong Kong) Limited (BSF HK). 3DBT is a tissue engineering company developing processes and tools for others to create functional tissues from a range of cell types. This includes a platform for generating structured tissues as well as media supplements that can accelerate and increase cell performance. Kerato utilizes multi-patented technology with expertise in tissue engineering and biomaterials to develop bio-equivalent corneal tissue.

Directors

    Last Annual
    September 30th, 2024
    Last Interim
    March 31st, 2025
    Incorporated
    September 5th, 2018
    Public Since
    July 26th, 2019
    No. of Employees
    4
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    gb flag iconLondon Stock Exchange
    Shares in Issue
    123,649,437

    BSFA Share Price Performance

    Upcoming Events for BSFA

    Similar to BSFA

    Picture of Allergy Therapeutics logo

    Allergy Therapeutics

    gb flag iconLondon Stock Exchange

    Picture of Animalcare logo

    Animalcare

    gb flag iconLondon Stock Exchange

    Picture of AstraZeneca logo

    AstraZeneca

    gb flag iconLondon Stock Exchange

    Picture of Beximco Pharmaceuticals logo

    Beximco Pharmaceuticals

    gb flag iconLondon Stock Exchange

    Picture of CRISM' Therapeutics logo

    CRISM' Therapeutics

    gb flag iconLondon Stock Exchange

    FAQ